Literature DB >> 1151467

Experimental cerebral oligemia and ischemia produced by intracranial hypertension. Part 2: Brain morphology.

L F Marshall, D I Graham, F Durity, R Lounsbury, F Welsh, T W Langfitt.   

Abstract

The authors studied the morphological sequelae of 15 minutes of cerebral oligemia (20 torr cerebral perfusion pressure) and complete cerebral ischemia produced by raised intracranial pressure in rabbits. Ischemic cell change was present in five of seven ischemic animals; it was most extensive in the striatum and hippocampus, with only a few ischemic nerve cells in the thalamus and neocortex. The brains of control and oligemic animals were normal. These results indicate the following: 1) ischemia is a more severe insult than oligemia; 2) compression ischemia results in a pattern of damage that differs from that produced by other types of ischemia; and 3) the method used to reduce cerebral perfusion pressure is an important factor in determining the pattern and extent of brain damage produced.

Entities:  

Mesh:

Year:  1975        PMID: 1151467     DOI: 10.3171/jns.1975.43.3.0318

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  4 in total

1.  [A case of centrogenic pulmonary edema].

Authors:  P Richer
Journal:  Can Anaesth Soc J       Date:  1978-05

2.  [Reticular activity and intracranial pressure. Acute and chronic intracranial hypertension (author's transl)].

Authors:  B George; O Benoit
Journal:  Acta Neurochir (Wien)       Date:  1977       Impact factor: 2.216

3.  Recovery of the electrocorticogram after incomplete and complete ischaemia of the brain.

Authors:  H Hirsch
Journal:  Acta Neurochir (Wien)       Date:  1982       Impact factor: 2.216

4.  The role of postischemic recirculation in the development of ischemic neuronal injury following complete cerebral ischemia.

Authors:  L W Jenkins; J T Povlishock; W Lewelt; J D Miller; D P Becker
Journal:  Acta Neuropathol       Date:  1981       Impact factor: 17.088

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.